Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28212132 | 0.82 | LMNA (0.48) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL1931354 | 0.79 | KDM4E (0.51) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL27684874 | 0.78 | LMNA (0.49) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL28575137 | 0.77 | HTT (0.50) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL6298510 | 0.76 | LMNA (0.47) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL2311192 | 0.76 | EPHX1 (0.66) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL11866123 | 0.76 | LMNA (0.55) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL22500155 | 0.75 | LMNA (0.39) | LMNAKDM4EALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL10779384 | 0.74 | ADORA2A (0.53) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL5094461 | 0.73 | ALDH1A1 (0.52) | LMNAGAAKDM4EALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103988099-B | Optical film and optical display device including the same | 第毛织株式会社 | 2017-03-01 | — | — | CN | claimed |
| US-8921445-B2 | Curable adhesive compositions | MITSUI CHEMICALS, INC. (JP) | 2014-12-30 | — | — | US | claimed |
| EP-2417210-B1 | CURABLE ADHESIVE COMPOSITIONS | PIXELOPTICS INC (US) | 2013-03-06 | — | — | EP | claimed |
| EP-2417210-A1 | CURABLE ADHESIVE COMPOSITIONS | Pixeloptics Inc. (US) | 2012-02-15 | — | — | EP | claimed |
| WO-2010118421-A1 | CURABLE ADHESIVE COMPOSITIONS | PIXELOPTICS, INC. (US) | 2010-10-14 | — | — | WO | claimed |
| US-20100261018-A1 | Curable Adhesive Compositions | PIXELOPTICS, INC. (US) | 2010-10-14 | — | — | US | claimed |
| EP-1858994-A1 | CURABLE ACRYLATE COMPOSITIONS, METHODS OF MAKING THE COMPOSITIONS AND ARTICLES MADE THEREFROM | General Electric Company (US) | 2007-11-28 | — | — | EP | claimed |
| US-7294657-B2 | Curable acrylate compositions, methods of making the compositions and articles made therefrom | GENERAL ELECTRIC COMPANY (US) | 2007-11-13 | — | — | US | claimed |
| WO-2006096643-A1 | CURABLE ACRYLATE COMPOSITIONS, METHODS OF MAKING THE COMPOSITIONS AND ARTICLES MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2006-09-14 | — | — | WO | claimed |
| US-20060199095-A1 | Curable acrylate compositions, methods of making the compositions and articles made therefrom | GENERAL ELECTRIC COMPANY | 2006-09-07 | — | — | US | claimed |
| US-20260133354-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260136706-A1 | STRUCTURED ULTRAVIOLET LIGHT SHIELDING ARTICLES AND SOLAR ARRAYS INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES CO (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4710370-A1 | WAVELENGTH-SELECTIVE MULTILAYER ARTICLES AND SOLAR ARRAYS INCLUDING THE SAME | 3M Innovative Properties Company (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4639242-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | 3M Innovative Properties Company (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4619797-A1 | STRUCTURED ULTRAVIOLET LIGHT SHIELDING ARTICLES AND SOLAR ARRAYS INCLUDING THE SAME | 3M Innovative Properties Company (US) | 2025-09-24 | — | — | EP | disclosed |
| US-20050250870-A1 | Polyalkoxylated bisphenol dimethacrylate; diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, neopentylglycol diacrylate, or 1,6-hexanediol diacrylate comonomers; thiomethacrylate-free; haze-free, nonstaining, noncracking, wear resistance; tinted lenses | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2005-11-10 | — | — | US | disclosed |
| US-20040194880-A1 | Rapid, nondeforming application of protective layer; depositing premeasured amount of curable glue on blank, contacting with coating, applying pressure and curing | ESSILOR INTERNATIONAL (FR) | 2004-10-07 | — | — | US | disclosed |
| EP-1426168-A2 | Inflatable membrane apparatus and process for transferring a coating onto a surface of a lens blank | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2004-06-09 | — | — | EP | disclosed |
| EP-1404510-A2 | PROCESS FOR TRANSFERRING A COATING ONTO A SURFACE OF A LENS BLANK | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003004255-A2 | PROCESS FOR TRANSFERRING A COATING ONTO A SURFACE OF A LENS BLANK | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260133354-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | ICAM1, CD63, CDH1 | LMNA 652/4885GAA 4218/4885KDM4E 3704/4885 |
| US-20260136706-A1 | STRUCTURED ULTRAVIOLET LIGHT SHIELDING ARTICLES AND SOLAR ARRAYS INCLUDING THE SAME | UFM1, UFL1, APOL1 | LMNA 483/4885GAA 3878/4885KDM4E 3342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.